Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test-Based Organized Screening Program in Italy: A Randomized Control Trial. | Synapse
January 23, 2026
Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test-Based Organized Screening Program in Italy: A Randomized Control Trial.
Key Points
To determine the effectiveness of artificial intelligence in detecting precancerous colonic lesions within a fecal immunochemical test-based screening program.
Conducted a randomized control trial in Italy.
Utilized artificial intelligence algorithms for lesion detection.
Implemented a fecal immunochemical test-based screening program.
AI did not significantly enhance detection of advanced adenoma detection rate (AADR).
There was a modest increase in withdrawal time during the screening process.
Abstract
In a FIT-based organized CRC screening setting, CADe did not enhance detection of AADR with a modest increase in withdrawal time. NCT04441580.